The DOI matches its Crossref record; 61 of the 62 references it cites were found in a registry or an index.
Nitric oxide bioavailability dysfunction involves in atherosclerosis
Abstract
The pathological characteristics of atherosclerosis (AS) include lipid accumulation, fibrosis formation and atherosclerotic plaque produced in artery intima, which leads to vascular sclerosis, lumen stenosis and irritates the ischemic changes of corresponding organs. Endothelial dysfunction was closely associated with AS. Nitric oxide (NO) is a multifunctional signaling molecule involved in the maintenance of metabolic and cardiovascular homeostasis. NO is also a potent endogenous vasodilator and enters for the key processes that suppresses the formation vascular lesion even AS. NO bioavailability indicates the production and utilization of endothelial NO in organisms, its decrease is related to oxidative stress, lipid infiltration, the expressions of some inflammatory factors and the alteration of vascular tone, which plays an important role in endothelial dysfunction. The enhancement of arginase activity and the increase in asymmetric dimethylarginine and hyperhomocysteinemia levels all contribute to AS by intervening NO bioavailability in human beings. Diabetes mellitus, obesity, chronic kidney disease and smoking, etc., also participate in AS by influencing NO bioavailability and NO level. Here, we reviewed the relationship between NO bioavailability and AS according the newest literatures.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Its decrease occurs in response to lipid infiltration, oxidative stress, and inflammatory factors, which play a vital role in endothelial dysfunction [153].”
From AMPK, Mitochondrial Function, and Cardiovascular Disease (2020) · cites this paper as [153]
In the citing paper
“Obesity, diabetes mellitus, smoking, chronic kidney disease, and so on participate in the pathogenesis of atherosclerosis via a mechanism of changing NO bioavailability [153].”
From AMPK, Mitochondrial Function, and Cardiovascular Disease (2020) · cites this paper as [153]
Citations
Cites
Endothelial Cell Dysfunction and the Pathobiology of Atherosclerosis
Gimbrone, M. A., & García‐Cardeña, G. (2016) · Circulation Research · doi:10.1161/circresaha.115.306301 · Cited by 3,694
Smoking and Cardiovascular Disease
Meßner, B., & Bernhard, D. (2014) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.113.300156 · Cited by 1,215
Endothelial dysfunction and vascular disease - a 30th anniversary update
Vanhoutte, P. M., Shimokawa, H., Feletou, M., & Tang, E. H. C. (2017) · Acta Physiologica · doi:10.1111/apha.12646 · Cited by 937
Vascular nitric oxide: Beyond eNOS
Zhao, Y., Vanhoutte, P. M., & Leung, S. W. S. (2015) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2015.09.002 · Cited by 875
Oxidant Mechanisms in Renal Injury and Disease
Ratliff, B. B., Abdulmahdi, W., Pawar, R. D., & Wolin, M. S. (2016) · Antioxidants and Redox Signaling · doi:10.1089/ars.2016.6665 · Cited by 712
Vascular oxidative stress, nitric oxide and atherosclerosis
Li, H., Horke, S., & Förstermann, U. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.09.001 · Cited by 678
Roles of Inflammation, Oxidative Stress, and Vascular Dysfunction in Hypertension
Dinh, Q. N., Drummond, G. R., Sobey, C. G., & Chrissobolis, S. (2014) · BioMed Research International · doi:10.1155/2014/406960 · Cited by 621
Endothelial dysfunction : the early predictor of atherosclerosis
Mudau, M., Genis, A., Lochner, A., & Strijdom, H. (2012) · Cardiovascular Journal of Africa · doi:10.5830/cvja-2011-068 · Cited by 521
Endothelial Dysfunction in Chronic Inflammatory Diseases
Steyers, C. M., & Miller, F. J. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms150711324 · Cited by 498
The Role of Asymmetric Dimethylarginine (ADMA) in Endothelial Dysfunction and Cardiovascular Disease
Sibal, L., Agarwal, S. C., Home, P., & Böger, R. H. (2010) · Current Cardiology Reviews · doi:10.2174/157340310791162659 · Cited by 433
Role of Polyphenols and Other Phytochemicals on Molecular Signaling
Upadhyay, S., & Dixit, M. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/504253 · Cited by 390
Karnik, S. S., Ünal, H., Kemp, J. R., Tirupula, K. C., Eguchi, S., Vanderheyden, P., & Thomas, W. G. (2015) · Pharmacological Reviews · doi:10.1124/pr.114.010454 · Cited by 313
Interleukin-17 causes Rho-kinase-mediated endothelial dysfunction and hypertension
Nguyen, H.-L., Chiasson, V. L., Chatterjee, P., Kopriva, S. E., Young, K. J., & Mitchell, B. M. (2012) · Cardiovascular Research · doi:10.1093/cvr/cvs422 · Cited by 309
Uncoupling of endothelial NO synthase in atherosclerosis and vascular disease
Li, H., & Förstermann, U. (2013) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2013.01.006 · Cited by 285
Regulation of obesity and insulin resistance by nitric oxide
Sansbury, B. E., & Hill, B. G. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.05.016 · Cited by 274 · cited 2×
“phorylation at Ser1176 and diminish NO production in the aorta of obese mice [51].”
Vascular endothelial dysfunction and pharmacological treatment
Su, J. B. (2015) · World Journal of Cardiology · doi:10.4330/wjc.v7.i11.719 · Cited by 251
Zhang, Q., Holland, W. L., Wilson, L., Tanner, J. M., Kearns, D., Cahoon, J. M., Pettey, D., Losee, J. T., Duncan, B., Gale, D. C., et al. (2012) · Diabetes · doi:10.2337/db11-1399 · Cited by 240
Tetrahydrobiopterin in Cardiovascular Health and Disease
Bendall, J. K., Douglas, G., McNeill, E., Channon, K. M., & Crabtree, M. J. (2014) · Antioxidants & Redox Signaling · doi:10.1089/ars.2013.5566 · Cited by 231
Therapeutic effects of inorganic nitrate and nitrite in cardiovascular and metabolic diseases
Omar, S. A., Webb, A. J., Lundberg, J. O., & Weitzberg, E. (2016) · Journal of Internal Medicine · doi:10.1111/joim.12441 · Cited by 175
Atherosclerotic cardiovascular disease: a review of initiators and protective factors
Ellulu, M. S., Patimah, I., Khaza’ai, H., Rahmat, A. B., Abed, Y. A., & Ali, F. (2016) · Inflammopharmacology · doi:10.1007/s10787-015-0255-y · Cited by 173
Obesity, inflammation and endothelial dysfunction.
Iantorno, M., Campia, U., Daniele, N. D., Nisticò, S. P., Forleo, G., Cardillo, C., & Tesauro, M. (2014) · PubMed · Cited by 169
Molecular Mechanisms of Endothelial NO Synthase Uncoupling
Luo, S., Han, L., Qin, H., & Xia, Y. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113196660746 · Cited by 169
Altered Nitric Oxide System in Cardiovascular and Renal Diseases
Lee, J., Bae, E. H., Kwon, S., & Kim, S. W. (2016) · Chonnam Medical Journal · doi:10.4068/cmj.2016.52.2.81 · Cited by 120
LOX-1 and ROS, inseparable factors in the process of endothelial damage
Lubrano, V., & Balzan, S. (2014) · Free Radical Research · doi:10.3109/10715762.2014.929122 · Cited by 109
Reactive Oxygen Species in Pathogenesis of Atherosclerosis
Goncharov, N. V., Avdonin, P. V., Nadeev, A. D., Zharkikh, I. L., & Jenkins, R. O. (2014) · Current Pharmaceutical Design · doi:10.2174/1381612820666141014142557 · Cited by 99
Oxidative Stress in Hypertension: Mechanisms and Therapeutic Opportunities
Brito, R., Castillo, G., González, J., Valls, N., & Rodrigo, R. (2015) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0035-1548765 · Cited by 88
Circulating Endothelial Microparticles: A Key Hallmark of Atherosclerosis Progression
Paudel, K. R., Panth, N., & Kim, D. (2016) · Scientifica · doi:10.1155/2016/8514056 · Cited by 82
Dhar, I., Caspar‐Bell, G., & Prasad, K. (2014) · International Journal of Angiology · doi:10.1055/s-0034-1396413 · Cited by 81
Ando, R., Ueda, S., Yamagishi, S., Miyazaki, H., Kaida, Y., Kaifu, K., Yokoro, M., Nakayama, Y., Obara, N., Fukami, K., et al. (2013) · Diabetes and Vascular Disease Research · doi:10.1177/1479164113486662 · Cited by 68
Li, Q., Atochin, D. N., Kashiwagi, S., Earle, J., Wang, A., Mandeville, E. T., Hayakawa, K., d’Uscio, L. V., Lo, E. H., Katušić, Z. S., et al. (2013) · Stroke · doi:10.1161/strokeaha.113.002073 · Cited by 65
Yu, S., Wong, S. L., Lau, C. W., Huang, Y., & Yu, C. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.02.096 · Cited by 64
Possible mechanisms of C-reactive protein mediated acute myocardial infarction
Asare, P. F., Wang, Y., Shi, Y., Agyemang, K., Akinyi, M., Zhang, Q., & Fan, G. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.04.010 · Cited by 60
Choi, S. H., Hong, E. S., & Lim, S. K. (2013) · Frontiers in Endocrinology · doi:10.3389/fendo.2013.00097 · Cited by 59
Xu, L., Wang, S., Li, B., Sun, A., Zou, Y., & Ge, J. (2014) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12463 · Cited by 55
Tian, X., Zhao, L., Song, X., Yan, Y., Liu, N., Li, T., Yan, B., & Liu, B. (2016) · BioMed Research International · doi:10.1155/2016/4847874 · Cited by 55
Nitric oxide status in patients with chronic kidney disease
Rao, P. V. L. N., Reddy, Y., Kiranmayi, V., Bitla, A., Krishna, G., & Sivakumar, V. (2014) · Indian Journal of Nephrology · doi:10.4103/0971-4065.147376 · Cited by 54
Li, T., Lu, X., Sun, Y., & Yang, X. (2016) · Food & Nutrition Research · doi:10.3402/fnr.v60.32010 · Cited by 53
da Silva, J. F., Correa, I. C., Diniz, T. F., Lima, P. M. D. A., dos Santos, R. L., Côrtes, S. F., Coimbra, C. C., & Lemos, V. S. (2016) · Frontiers in Physiology · doi:10.3389/fphys.2016.00386 · Cited by 52
Yan, T., Li, Q., Zhang, X., Wei-kang, W., Sun, J., Li, L., Zhang, Q., & Tan, H. (2010) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2010.05438.x · Cited by 50
Suliburska, J., Bogdanski, P., Szulinska, M., Pupek-Musialik, D., & Jablecka, A. (2014) · European Journal of Nutrition · doi:10.1007/s00394-013-0533-7 · Cited by 47
Endothelium-Derived Nitric Oxide as an Antiatherogenic Mechanism: Implications for Therapy
Sukhovershin, R. A., Yepuri, G., & Ghebremariam, Y. T. (2015) · Methodist DeBakey Cardiovascular Journal · doi:10.14797/mdcj-11-3-166 · Cited by 46
Ou, Z., Chen, J., Dai, W.-P., Liu, X., Yang, Y., Li, Y., Lin, Z., Wang, T.-T., Wu, Y., Su, D.-H., et al. (2016) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00218.2016 · Cited by 46
Angiotensin II limits NO production by upregulating arginase through a p38 MAPK–ATF-2 pathway
Shatanawi, A., Lemtalsi, T., Yao, L., Patel, C., Caldwell, R. B., & Caldwell, R. W. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.10.042 · Cited by 43
Sandoo, A., Dimitroulas, T., Hodson, J. A., Smith, J., Douglas, K., & Kitas, G. D. (2014) · Rheumatology · doi:10.1093/rheumatology/keu349 · Cited by 40
Suwanpradid, J., Rojas, M., Behzadian, M. A., Caldwell, R. W., & Caldwell, R. B. (2014) · PLoS ONE · doi:10.1371/journal.pone.0110604 · Cited by 39
Homocysteine reduces protein S-nitrosylation in endothelium
Chen, Y., Zhao, S., Wang, Y., Li, Y., Bai, L., Liu, R., Fan, J., & Liu, E. (2014) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2014.1920 · Cited by 33
Cryptotanshinone inhibits TNF-α-induced early atherogenic events in vitro
Ahmad, Z., Ng, C. T., Fong, L. Y., Bakar, N. A. A., Hussain, N. H. M., Ang, K. P., Ee, G. C. L., & Hakim, M. N. (2016) · The Journal of Physiological Sciences · doi:10.1007/s12576-015-0410-7 · Cited by 33
Potential of Food and Natural Products to Promote Endothelial and Vascular Health
Auger, C., Amissi, S., Nguyen, P. N., Chabert, P., Idris-Khodja, N., & Schini‐Kerth, V. B. (2016) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000382 · Cited by 33
Arginase as a Critical Prooxidant Mediator in the Binomial Endothelial Dysfunction-Atherosclerosis
Rabelo, L. A., Ferreira, F. O., Nunes-Souza, V., da Fonseca, L. J. S., & Goulart, M. O. F. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/924860 · Cited by 31
Purinergic Signalling and Endothelium
Burnstock, G. (2016) · Current Vascular Pharmacology · doi:10.2174/1570161114666151202204948 · Cited by 28
Lin, F., Tsao, N.-W., Shih, C., Lin, Y., Yeh, J., Chen, J., Nakagami, H., Morishita, R., Sawamura, T., & Huang, C. (2015) · PLoS ONE · doi:10.1371/journal.pone.0123971 · Cited by 24
Lin, Y.-J., Hsu, C., Lo, M., Huang, C.-F., Chien, S., & Tain, Y. (2012) · Circulation Journal · doi:10.1253/circj.cj-12-0602 · Cited by 23
Modulating DDAH/NOS Pathway to Discover Vasoprotective Insulin Sensitizers
Lai, L., & Ghebremariam, Y. T. (2015) · Journal of Diabetes Research · doi:10.1155/2016/1982096 · Cited by 21
Ratio Of Serum Asymmetric Dimethyl Arginine (ADMA)/ Nitric Oxide in Coronary Artery Disease patients
Shivkar, R. R. (2014) · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH · doi:10.7860/jcdr/2014/7849.4665 · Cited by 20
Oxidative stress in rats with hyperhomo-cysteinemia and intervention effect of lutein.
Wang, S., Wang, M., Zhang, S., & Жао, Л. (2014) · PubMed · Cited by 20
Zeng, A. V. M. L., & Pennathur, J. B. S. (2015) · Journal of Proteomics & Bioinformatics · doi:10.4172/jpb.s14-001 · Cited by 18
Bartnicki, P., Kowalczyk, M., Franczyk, B., Baj, Z., & Rysz, J. (2016) · Current Vascular Pharmacology · doi:10.2174/1570161114666160112142403 · Cited by 16
Impact of Superoxide Dismutase Mimetic AEOL 10150 on the Endothelin System of Fischer 344 Rats
Ganesh, D., Kumarathasan, P., Thomson, E. M., St-Germain, C., Blais, E., Crapo, J. D., & Vincent, R. (2016) · PLoS ONE · doi:10.1371/journal.pone.0151810 · Cited by 13
Brunner, M., Gruber, M., Schmid, D., Baran, H., & Moeslinger, T. (2015) · EXCLI journal · doi:10.17179/excli2015-151 · Cited by 12
Az oxidatív stressz szerepe szívelégtelenségben
Gál, R., & Halmosi, R. (2015) · Orvosi Hetilap · doi:10.1556/650.2015.30301 · Cited by 7
[Role of oxidative stress in heart failure].
Tsutsui, H. (2003) · PubMed · Cited by 6
Cited by
Sorted by citations
Sharifi-Rad, M., Anil Kumar, N. V., Zucca, P., Varoni, E. M., Dini, L., Panzarini, E., Rajkovic, J., Tsouh Fokou, P. V., Azzini, E., Peluso, I., et al. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00694 · Cited by 1,971
Pathophysiology of Atherosclerosis
Jebari‐Benslaiman, S., Galicia-García, U., Larrea, A., Olaetxea, J. R., Alloza, I., Vandenbroeck, K., Benito‐Vicente, A., & Martı́n, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23063346 · Cited by 1,166
Yuan, T., Yang, T., Chen, H., Fu, D., Hu, Y., Wang, J., Yuan, Q., Yu, H., Xu, W., & Xie, X. (2018) · Redox Biology · doi:10.1016/j.redox.2018.09.025 · Cited by 766
Atherosclerosis and Inflammation: Insights from the Theory of General Pathological Processes
Gusev, E., & Sarapultsev, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24097910 · Cited by 357
AMPK, Mitochondrial Function, and Cardiovascular Disease
Wu, S., & Zou, M.-H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21144987 · Cited by 286
Metadata
- Authors
- Chen, J.-Y., Ye, Z.-X., Wang, X.-F., Chang, J., Yang, M.-W., Zhong, H.-H., Hong, F.-F., & Yang, S.-L.
- Affiliations
- Nanchang University (CN)
- Corresponding author
- Hong, Fen-fang
- Yang, Shu-long
- Venue
- Biomedicine & Pharmacotherapy
- Publisher
- Elsevier BV
- Published
- 2018-01
- Volume
- 97
- Pages
- 423-428
- ISSN
- 0753-3322 (ISSN-L)
- OpenAlex
- W2765547578
- Cited by
- 216
- References
- 62
- Citations by year
- 2026: 18 · 2025: 35 · 2024: 27 · 2023: 29 · 2022: 25 · 2021: 29 · 2020: 27 · 2019: 17 · 2018: 7
- FWCI
- 1.78
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- Biomedicine & Pharmacotherapy (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (81260504, 81660151, 81660751)
- Key Research and Development Program of Jiangxi Province (20161BBG70067)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Keywords
- nitric oxide bioavailability, atherosclerosis, endothelial dysfunction, oxidative stress, asymmetric dimethylarginine, hyperhomocysteinemia, arginase, vascular inflammation, diabetes mellitus, obesity, chronic kidney disease, smoking, lipid accumulation, atherosclerotic plaque
- MeSH terms
- Animals, Arginine, Biological Availability, Cardiovascular Diseases, Endothelium, Vascular, Humans, Nitric Oxide, Obesity, Smoking, Vasodilation, Oxidative Stress, Atherosclerosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
